Je was op zoek naar: echo (IJslands - Engels)

millibil lcp echo
lcp echo interval

senda ppp echo pakka
send ppp & echo packets

heildarupplýsingar úr echo og thrive rannsóknunum
pooled data from the echo and thrive trials

við slembival í echo var raðað eftir veirufjölda við skimun.
in echo, randomisation was stratified by screening viral load.

Í greiningunni fólust upplýsingar um 690 sjúklinga í echo og 678 sjúklinga í thrive sem luku 96 vikna meðferð eða hættu fyrr.
this analysis included 690 patients in echo and 678 patients in thrive who had completed 96 weeks of treatment or discontinued earlier.

bakgrunnsmeðferðin í echo var bundin við n(t)rti, tenofovir disoproxil fumarat ásamt emtricitabini.
in echo, the br was fixed to the n(t)rtis, tenofovir disoproxil fumarate plus emtricitabine.

lagt var mat á eftirtalda endapunkta: eðlileg alt-gildi, lækkun á ldl-kólesteróli, lækkun á öðru kólesteróli en hdl-kólesteróli, eðlileg ast-gildi, lækkun á þríglýseríðum, hækkun á hdl- kólesteróli, minnkun á fituinnihaldi lifrar metið með mege-segulómun (e. multi-echo gradient echo magnetic resonance imaging) og bót á fituhrörnun lifrar mælt með formmælingum.
the following endpoints were assessed: normalisation of alt, decrease in ldl-cholesterol, decrease in non-hdl-cholesterol, normalisation of ast, decrease in triglycerides, increase in hdl- cholesterol, decrease in liver fat content assessed by multi-echo gradient echo magnetic resonance imaging (mege-mri), and improvement in hepatic steatosis measured by morphometry.